Development and Validation of an EHR-based Algorithm for Identifying Pneumocystis jirovecii Pneumonia

YU KITAMURA; MASAMI TSUCHIYA; HIROTOSHI IIHARA; SHUJI SAKURAI; JUNKI ENDO; KEISUKE KUMADA; YUKARI TSUBATA

doi:10.21873/invivo.14322

Article Information

vol. 40 no. 3 1715-1721

DOI

https://doi.org/10.21873/invivo.14322

PMID

42049409

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received February 6, 2026
Revision received March 8, 2026
Accepted March 16, 2026
Published online April 28, 2026.

Copyright © 2026 The Author(s). Published by the International Institute of Anticancer Research. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Author Information

YU KITAMURA¹,
MASAMI TSUCHIYA² ⇑,
HIROTOSHI IIHARA³,⁴,⁵,
SHUJI SAKURAI³,
JUNKI ENDO¹,
KEISUKE KUMADA⁴ and
YUKARI TSUBATA¹,⁵

¹Department of Respirology, Graduate School of Medicine, Gifu University, Gifu, Japan;
²Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan;
³Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
⁴Patient Safety Division, Gifu University Hospital, Gifu, Japan;
⁵Cancer Center, Gifu University Hospital, Gifu, Japan

Masami Tsuchiya, PhD, Division of Drug Informatics, Keio University Faculty of Pharmacy, 1-5-30 Shibakoen, Minato-ku, Tokyo, 105-8512, Japan. E-mail: m-tsuchiya{at}keio.jp

View Full Text